What is virotherapy?

Oncological virotherapy is a cancer treatment using a unique virus that is able to detect and eliminate malignant tumour cells in a person’s body.

After the virus is introduced into the patient’s body it finds and infects malignant tumour cells. This process is known as oncotropism. The virus multiplies in the malignant tumour cells and kills them. This process is known as oncolysis. The viruses not only destroy cancer cells, but also mobilise the immune system’s natural defence mechanisms including its ability to defend itself against tumour cells.

Not unlike chemotherapy, the goal of virotherapies is to attack cancer cells, but virotherapy has several advantages:

  • virotherapy selectively eradicates tumour cells without damaging healthy cells in the body;

  • virotherapy stimulates the body’s natural defence mechanisms by activating the immune system, which is often suppressed by other treatments;

  • virotherapy can be used against tumours that don’t respond well to radiation or chemotherapy, such as melanomas;

  • virotherapy can be used at various stages throughout the treatment process: before or after surgery and also between radiation or chemotherapy treatments.

Virotherapy is recognised as a safe and effective cancer treatment method. It is a treatment method that protects the body with minimal side effects. The most commonly experienced side effect is a heightened (subfebrile) body temperature for one to three days.

More information: www.virotherapy.eu